Targeting Fibrosis by inhibiting Chemotaxis
A new revolution in asthma care is on its way. We are developing a new, inhalable daily medication that halts and reverses the structural lung damage that occurs in asthma.
A new revolution in asthma care is on its way. We are developing a new, inhalable daily medication that halts and reverses the structural lung damage that occurs in asthma.
